Do you want to make lowering the risk of fracture a priority?
You may be at risk for fracture from postmenopausal osteoporosis if you:
- Have had an osteoporotic fracture
- Have other risk factors such as tobacco use, alcohol use (more than 2 drinks per day) or a family history of osteoporosis
- Are taking other drugs that could affect bone health
- Did not do well on, or could not tolerate, other osteoporosis medications
Created for women with osteoporosis
at high risk for fracture after menopause
TYMLOS is a daily injection with a pen.
The pen needle is about the length of an eyelash.
After first use no refrigeration is required, so you can take it with you for up to 30 days at room temperature.
The pen has enough medicine in it for 30 days.
You could pay $4 a month for TYMLOS
Commercially insured patients may be eligible* for savings support — and may pay as little as $4 a month.
Now you can download the Together with Tymlos Savings Card to Apple® Wallet. Add to Wallet prior to filling your first prescription to receive helpful refill reminders. To learn more, visit TYMLOS.com/savings from your iPhone®.To learn more or to begin, tap the Apple® Wallet icon below. For other types of mobile devices, access the savings card using the Download button.
iPhone® users can download the Together with Tymlos Savings Card to Apple Wallet®. Add it before filling your first prescription to get helpful refill reminders. Learn more by tapping the Apple Wallet icon below. For other smartphone users, use the Download button.
*Eligibility, rules and restrictions apply.
Show off your
Are you taking TYMLOS? Your story could help other women with postmenopausal osteoporosis. We’d love to hear from you!
What is the most important information I should know about TYMLOS?
TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma. READ MORE